Premium
EXTRA AMNIOTIC PROSTAGLANDINS IN THE MANAGEMENT OF INTRAUTERINE FETAL DEATH, ANENCEPHALY AND HYDATIDIFORM MOLE
Author(s) -
Embrey M. P.,
Calder A. A.,
Hillier K.
Publication year - 1974
Publication title -
bjog: an international journal of obstetrics and gynaecology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.157
H-Index - 164
eISSN - 1471-0528
pISSN - 1470-0328
DOI - 10.1111/j.1471-0528.1974.tb00363.x
Subject(s) - anencephaly , medicine , prostaglandin , obstetrics , fetus , mole , amniotic fluid , fetal death , pregnancy , gynecology , biology , genetics
Summary Prostaglandin E 2 or prostaglandin F 2α was administered extra‐amniotically in the treatment of 22 cases of intrauterine fetal death, two of anencephaly and one of hydatidiform mole. Delivery was achieved in 24 out of the 25 patients. The choice of the extra‐amniotic route of administration appeared to result in fewer side effects than have been encountered during intravenous prostaglandin therapy in the treatment of these conditions.